Regencell Bioscience RGC
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$400.3K (6 inflow days, 14 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 88.7% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 0.20% to 0.07% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Morgan Stanley | Public Company | 2026/Q3 | +35,537 | 0.0% |
| Morgan Stanley Investment Management Inc. | Mutual Fund | 2026/Q3 | +35,537 | 0.0% |
| Savant Capital, LLC | Mutual Fund | 2026/Q3 | +18,255 | 0.0% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +1,359 | 0.1% |
| Larson Financial Group, LLC | Mutual Fund | 2026/Q3 | +931 | 0.0% |
| Osaic Wealth, Inc. | Private Company | 2026/Q3 | +878 | 0.0% |
| Ameritas Investment Partners, Inc. | Mutual Fund | 2026/Q3 | +421 | 0.0% |
| Superior Planning, LLC | Family Office/Trust | 2026/Q3 | +251 | 0.0% |
| FMR | Mutual Fund | 2026/Q3 | +1,541 | 0.1% |
| FMR | Mutual Fund | 2026/Q3 | +1,541 | 0.1% |
| Alyeska Investment Group, L.P. | Hedge Fund | 2026/Q3 | +416,261 | 0.1% |
| Legal & General Investment Management | Mutual Fund | 2026/Q3 | +118,097 | 0.0% |
| Jane Street Group, LLC | Private Company | 2026/Q3 | +98,348 | 0.0% |
| XTX Markets Limited | Private Company | 2026/Q3 | +60,061 | 0.0% |
| Quadrature Capital Limited | Hedge Fund | 2026/Q3 | +41,750 | 0.0% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 26 May 2026 | Wing Yan Lo | Independent Director | Derivative Sale to Issuer | -70,600 | – | 521,630 |
| 26 May 2026 | Yee Wah Hui | Independent Director | Derivative Sale to Issuer | -19,000 | – | 573,230 |
| 17 Mar 2026 | Yat-Gai Au | Chairperson & CEO | Initial Statement of Beneficial | +0 | – | 437,896,116 |
| 17 Mar 2026 | Wing Yan Lo | Independent Director | Initial Statement of Beneficial | +0 | – | 592,230 |
| 17 Mar 2026 | Yee Wah Hui | Independent Director | Initial Statement of Beneficial | +0 | – | 592,230 |
| 17 Mar 2026 | Yat-Pui Au | Chief Business Officer | Initial Statement of Beneficial | +0 | – | 581,514 |
| 17 Mar 2026 | Hoor Han Lo | Independent Director | Initial Statement of Beneficial | +0 | – | 592,230 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 349,507 | 0.1% | 1.0 |
| 15 Oct 2026 | 440,717 | 0.1% | 1.0 |
| 30 Sep 2026 | 656,182 | 0.1% | 7.3 |
| 15 Sep 2026 | 801,244 | 0.2% | 3.1 |
| 31 Aug 2026 | 951,697 | 0.2% | 8.1 |
| 14 Aug 2026 | 990,338 | 0.2% | 4.7 |
No comments yet — be the first to weigh in on RGC.
Sign in to join the discussion.